From bench to bedside: The journey of a cancer treatment
1 in 2 of us will get a cancer diagnosis in our lifetime but for 40 years, researchers at Newcastle have been fighting for people with cancer. They have discovered and developed life changing cancer treatments and led change in the ways that we prevent and diagnose cancer - all to give people with cancer the very best chance of living longer, healthier and happier lives. 

Join Professor Ruth Plummer, clinical lead for the Newcastle University Centre for Cancer, as she talks about how cancer treatments make their way from discovery in the lab to the people who need them, and how the treatments that Newcastle has developed have made a difference to people all over the world. 

About Ruth Plummer:
Raised in the North East, Ruth Plummer is Professor of Experimental Cancer Medicine at Newcastle University. She is Director of the Sir Bobby Robson Cancer Trials Research Centre within the Northern Centre for Cancer Care and she leads the Newcastle Experimental Cancer Medicine Centre and the CRUK Newcastle Cancer Centre.

Her clinical practice involves leading one of the busiest early phase cancer trials units in the UK and also treating skin cancer, with a portfolio of trials across all phases of drug development. Her research interests are in the field of DNA repair and early clinical trials of new types of cancer therapy.

Ruth was elected a Fellow of the Academy of Medical Sciences in 2018 for her work developing PARP inhibitors as novel cancer treatments and in 2021 she was awarded the ESMO-TAT Lifetime Achievement award for her work in early phase trials.

Find out more and support cancer research at Newcastle University: ncl.ac.uk/cancer/donate

свернуть